ECONOMIC BURDEN AMONG CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH AND WITHOUT TYPE 2 DIABETES (T2D) IN A COMMERCIALLY INSURED/MEDICARE ADVANTAGE (MA) POPULATION IN THE UNITED STATES (US)

被引：0
|
作者：
Chung, H. [1 ]
Thomas, N. [1 ]
Willey, V [1 ]
Kong, S. X. [2 ]
Singh, R. [2 ]
Farej, R. [2 ]
Williamson, T. [2 ]
机构：
[1] HealthCore Inc, Wimlington, DE USA
[2] Bayer US LLC, Whippany, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE242
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [31] Inside CKD: modelling the future global burden of chronic kidney disease in patients with type 2 diabetes
    Tangri, N.
    Arnlov, J.
    Batista, M. C.
    Chadban, S.
    Chertow, G. M.
    De Nicola, L.
    Halimi, J. -M.
    Kanda, E.
    Li, G.
    Mennini, F. S.
    Navarro-Gonzalez, J. F.
    Power, A.
    Sultan, A. A.
    Webber, L.
    Wish, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 322 - 322
  • [32] Risk Factors and Economic Burden of Hypoglycemia in Older Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Basal Insulin (BI) in a US Medicare Advantage Population
    Escalada, Javier
    Liao, Laura
    Pan, Chunshen
    Wang, Hongwei
    DIABETES, 2015, 64 : A254 - A254
  • [33] Regional Variations in Chronic Kidney Disease Prevalence among Patients with or without Type 2 Diabetes (RADAR) in the US
    Feng, Xue
    Farej, Ryan
    Xia, Fang
    Gaiser, Andrew S.
    Kong, Sheldon
    Elliott, Jay
    Lindemann, Stefanie
    Singh, Rakesh
    DIABETES, 2020, 69
  • [34] Risk factor and economic burden of hypoglycaemia in elderly patients with type 2 diabetes mellitus initiating Basal Insulin (BI) in a US medicare advantage population
    Liao, L.
    Wang, H.
    Pan, C.
    Bala, M.
    Escalada, J.
    DIABETOLOGIA, 2015, 58 : S410 - S411
  • [35] Racial/Ethnic Disparities in Life Years Lost (LYL) to Type 2 Diabetes (T2D) in Medicare Beneficiaries in the United States
    Wang, Yu
    Shao, Yixue
    Cheng, Yiling
    Imperatore, Giuseppina
    Luman, Elizabeth
    Holliday, Christopher S.
    Zhang, Ping
    DIABETES, 2024, 73
  • [36] Incidence and Progression of Chronic Kidney Disease among Patients With and Without Type 2 Diabetes
    Nichols, Gregory A.
    Deruaz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    DIABETES, 2017, 66 : A656 - A656
  • [37] Evaluation of the Progression of Chronic Kidney Disease (CKD) and Associated Costs in US Patients with Type 2 Diabetes Mellitus (T2DM)
    Neslusan, Cheryl
    Montejano, Leslie
    O'Brien, Duncan
    Cuddihy, Robert
    DIABETES, 2016, 65 : A327 - A328
  • [38] Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
    Wendy L. St. Peter
    Haifeng Guo
    Shaum Kabadi
    David T. Gilbertson
    Yi Peng
    Trudy Pendergraft
    Suying Li
    BMC Nephrology, 19
  • [39] Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
    St Peter, Wendy L.
    Guo, Haifeng
    Kabadi, Shaum
    Gilbertson, David T.
    Peng, Yi
    Pendergraft, Trudy
    Li, Suying
    BMC NEPHROLOGY, 2018, 19
  • [40] Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Cherney, David
    Charbonnel, Bernard
    Mcguire, Darren K.
    Cosentino, Francesco
    Shih, Weichung J.
    Liu, Jie
    Frederich, Robert
    Mancuso, James P.
    Raji, Annaswamy
    Gantz, Ira
    DIABETES, 2021, 70
12345